Cite
HARVARD Citation
Kuter, D. et al. (2022). Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study. American journal of hematology. 97 (6), pp. 691-699. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kuter, D. et al. (2022). Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study. American journal of hematology. 97 (6), pp. 691-699. [Online].